MSH|^~\&|LAB|STL||SL126259|20090511121540||ORU^R01|20090511585402327590|P|2.3|||||||
PID|1|VS1234567890|KS847271C|10106|TEST^JOHN^F||19640209|M||||||||||0000002|||||||||||||
ORC|RE|0000002|KS847271C||CM|||||||^PHYS WELLNESS NETWORK^^||||||||
OBR|1|0000002|KS847271C|$CPTO^LIPID PANEL WITH REFLEX TO DIRECT LDL^^$CPTO^LIPID PANEL WITH REFLEX TO DIRECT LDL|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^||||^^^$CPTO^TRIGLYCERIDES||20090511111300|||F|||||||||||||||||||
OBX|1|TX|$CPTO^COPY(IES) SENT TO:^^$CPTO^COPY(IES) SENT TO:^||||||||P|||20090511111300||||
NTE|1||  |
NTE|2||          PHYSICIAN WELLNESS NETWORK|
NTE|3||          1201 S COLLEGEVILLE RD|
NTE|4||          COLLEGEVILLE, PA 19426-2998|
OBR|2|0000002|KS847271C|14852SB=^LIPID PANEL WITH REFLEX TO DIRECT LDL^^14852SB=^LIPID PANEL WITH REFLEX TO DIRECT LDL|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^||||^^^896SB=^TRIGLYCERIDES|KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25002900^TRIGLYCERIDES^^25002900^TRIGLYCERIDES^||115|mg/dL|<150|N|||F|||20090511111300|KS^^L|||
OBR|3|0000002|KS847271C|14852SB=^^^14852SB=^|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^||||^^^334SB=^CHOLESTEROL, TOTAL|KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25003000^CHOLESTEROL, TOTAL^^25003000^CHOLESTEROL, TOTAL^||174|mg/dL|125-200|N|||F|||20090511111300|KS^^L|||
OBR|4|0000002|KS847271C|14852SB=^^^14852SB=^|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^||||^^^608SB=^HDL CHOLESTEROL|KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25015900^HDL CHOLESTEROL^^25015900^HDL CHOLESTEROL^||72|mg/dL|> OR = 46|N|||F|||20090511111300|KS^^L|||
OBR|5|0000002|KS847271C|14852SB=^^^14852SB=^|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^||||^^^%8841SB^LDL-CHOLESTEROL|KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25016900^LDL-CHOLESTEROL^^25016900^LDL-CHOLESTEROL^||79|mg/dL (calc)|<130|N|||F|||20090511111300|KS^^L|||
NTE|1|| |
NTE|2||DESIRABLE RANGE <100 MG/DL FOR PATIENTS WITH CHD OR|
NTE|3||DIABETES AND <70 MG/DL FOR DIABETIC PATIENTS WITH|
NTE|4||KNOWN HEART DISEASE.|
NTE|5|| |
OBR|6|0000002|KS847271C|14852SB=^^^14852SB=^|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^||||^^^%8842SB^CHOL/HDLC RATIO|KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25017000^CHOL/HDLC RATIO^^25017000^CHOL/HDLC RATIO^||2.4|(calc)|< OR = 5.0|N|||F|||20090511111300|KS^^L|||
OBR|7|0000002|KS847271C|19694SB=^BIOMETRICS (HT,WT,BP)^^19694SB=^BIOMETRICS (HT,WT,BP)|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^||||^^^19689SB=^HEIGHT|KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|97014701^FEET^^97014701^FEET^||5||||||F|||20090511111300|KS^^L|||
OBX|2|NM|97014702^INCHES^^97014702^INCHES^||8||||||F|||20090511111300|KS^^L|||
OBR|8|0000002|KS847271C|19694SB=^^^19694SB=^|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^||||^^^19690SB=^WEIGHT|KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|97014703^WEIGHT^^97014703^WEIGHT^||170|lbs|||||F|||20090511111300|KS^^L|||
OBR|9|0000002|KS847271C|19694SB=^^^19694SB=^|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^||||^^^19691SB=^BLOOD PRESSURE|KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|97014704^SYSTOLIC^^97014704^SYSTOLIC^||122||||||F|||20090511111300|KS^^L|||
OBX|2|NM|97014705^DIASTOLIC^^97014705^DIASTOLIC^||78||||||F|||20090511111300|KS^^L|||
OBR|10|0000002|KS847271C|285SB=^BILIRUBIN, DIRECT^^285SB=^BILIRUBIN, DIRECT|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25001800^BILIRUBIN, DIRECT^^25001800^BILIRUBIN, DIRECT^||0.1|mg/dL|< OR = 0.2|N|||F|||20090511111300|KS^^L|||
OBR|11|0000002|KS847271C|482SB=^GGT^^482SB=^GGT|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25002200^GGT^^25002200^GGT^||12|U/L|3-70|N|||F|||20090511111300|KS^^L|||
OBR|12|0000002|KS847271C|823SB=^ALT^^823SB=^ALT|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25002400^ALT^^25002400^ALT^||15|U/L|6-40|N|||F|||20090511111300|KS^^L|||
OBR|13|0000002|KS847271C|905SB=^URIC ACID^^905SB=^URIC ACID|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25002500^URIC ACID^^25002500^URIC ACID^||4.8|mg/dL|2.5-7.0|N|||F|||20090511111300|KS^^L|||
OBR|14|0000002|KS847271C|7573SB=^IRON AND TOTAL IRON BINDING CAPACITY^^7573SB=^IRON AND TOTAL IRON BINDING CAPACITY|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25002600^IRON, TOTAL^^25002600^IRON, TOTAL^||89|mcg/dL|40-160|N|||F|||20090511111300|KS^^L|||
OBX|2|NM|25002700^IRON BINDING CAPACITY^^25002700^IRON BINDING CAPACITY^||290|mcg/dL|250-450|N|||F|||20090511111300|KS^^L|||
OBX|3|NM|25002800^% SATURATION^^25002800^% SATURATION^||31|% (calc)|15-50|N|||F|||20090511111300|KS^^L|||
OBR|15|0000002|KS847271C|34389SB=^COMPREHENSIVE METABOLIC PNL W/EGFR W/O CO2, ALT^^34389SB=^COMPREHENSIVE METABOLIC PNL W/EGFR W/O CO2, ALT|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|25000000^GLUCOSE^^25000000^GLUCOSE^||96|mg/dL|65-99|N|||F|||20090511111300|KS^^L|||
NTE|1||            FASTING REFERENCE INTERVAL|
OBX|2|NM|25000100^UREA NITROGEN (BUN)^^25000100^UREA NITROGEN (BUN)^||13|mg/dL|7-25|N|||F|||20090511111300|KS^^L|||
OBX|3|NM|25000200^CREATININE^^25000200^CREATININE^||1.20|mg/dL|0.60-1.10|H|||F|||20090511111300|KS^^L|||
OBX|4|NM|25000210^eGFR NON-AFR. AMERICAN^^25000210^eGFR NON-AFR. AMERICAN^||47|mL/min/1.73m2|> OR = 60|L|||F|||20090511111300|KS^^L|||
OBX|5|NM|25000220^eGFR AFRICAN AMERICAN^^25000220^eGFR AFRICAN AMERICAN^||56|mL/min/1.73m2|> OR = 60|L|||F|||20090511111300|KS^^L|||
OBX|6|NM|25000300^BUN/CREATININE RATIO^^25000300^BUN/CREATININE RATIO^||11|(calc)|6-22|N|||F|||20090511111300|KS^^L|||
OBX|7|NM|25000400^SODIUM^^25000400^SODIUM^||142|mmol/L|135-146|N|||F|||20090511111300|KS^^L|||
OBX|8|NM|25000500^POTASSIUM^^25000500^POTASSIUM^||4.3|mmol/L|3.5-5.3|N|||F|||20090511111300|KS^^L|||
OBX|9|NM|25000600^CHLORIDE^^25000600^CHLORIDE^||106|mmol/L|98-110|N|||F|||20090511111300|KS^^L|||
OBX|10|NM|25001000^CALCIUM^^25001000^CALCIUM^||9.7|mg/dL|8.6-10.2|N|||F|||20090511111300|KS^^L|||
OBX|11|NM|25001300^PROTEIN, TOTAL^^25001300^PROTEIN, TOTAL^||7.6|g/dL|6.2-8.3|N|||F|||20090511111300|KS^^L|||
OBX|12|NM|25001400^ALBUMIN^^25001400^ALBUMIN^||4.6|g/dL|3.6-5.1|N|||F|||20090511111300|KS^^L|||
OBX|13|NM|25001500^GLOBULIN^^25001500^GLOBULIN^||3.0|g/dL (calc)|2.2-3.9|N|||F|||20090511111300|KS^^L|||
OBX|14|NM|25001600^ALBUMIN/GLOBULIN RATIO^^25001600^ALBUMIN/GLOBULIN RATIO^||1.5|(calc)|1.0-2.1|N|||F|||20090511111300|KS^^L|||
OBX|15|NM|25001700^BILIRUBIN, TOTAL^^25001700^BILIRUBIN, TOTAL^||0.6|mg/dL|0.2-1.2|N|||F|||20090511111300|KS^^L|||
OBX|16|NM|25002000^ALKALINE PHOSPHATASE^^25002000^ALKALINE PHOSPHATASE^||45|U/L|33-130|N|||F|||20090511111300|KS^^L|||
OBX|17|NM|25002300^AST^^25002300^AST^||21|U/L|10-35|N|||F|||20090511111300|KS^^L|||
OBR|16|0000002|KS847271C|10124SB=^CARDIO CRP(R)^^10124SB=^CARDIO CRP(R)|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|45203715^CARDIO CRP(R)^^45203715^CARDIO CRP(R)^||0.7|mg/L ||N|||F|||20090511111300|KS^^L|||
NTE|1|| |
NTE|2||LOWER RELATIVE CARDIOVASCULAR RISK ACCORDING TO AHA/CDC |
NTE|3||GUIDELINES. |
NTE|4|| |
NTE|5||FOR AGES > 17 YEARS:|
NTE|6|| |
NTE|7||CCRP mg/L    RISK ACCORDING TO AHA/CDC GUIDELINES  |
NTE|8||---------    ------------------------------------|
NTE|9||<1.0         LOWER RELATIVE CARDIOVASCULAR RISK.|
NTE|10||1.0-3.0      AVERAGE RELATIVE CARDIOVASCULAR RISK.|
NTE|11||3.1-10.0     HIGHER RELATIVE CARDIOVASCULAR RISK.|
NTE|12||             CONSIDER RETESTING IN 1 TO 2 WEEKS TO|
NTE|13||             EXCLUDE A BENIGN TRANSIENT ELEVATION |
NTE|14||             IN THE BASELINE CRP VALUE SECONDARY |
NTE|15||             TO INFECTION OR INFLAMMATION.|
NTE|16||>10.0        PERSISTENT ELEVATION, UPON RETESTING,|
NTE|17||             MAY BE ASSOCIATED WITH INFECTION AND |
NTE|18||             INFLAMMATION.|
NTE|19|| |
OBR|17|0000002|KS847271C|457SB=^FERRITIN^^457SB=^FERRITIN|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|55059300^FERRITIN^^55059300^FERRITIN^||173|ng/mL|10-232|N|||F|||20090511111300|KS^^L|||
OBR|18|0000002|KS847271C|866SB=^T4, FREE^^866SB=^T4, FREE|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|55070600^T4, FREE^^55070600^T4, FREE^||1.1|ng/dL|0.8-1.8|N|||F|||20090511111300|KS^^L|||
OBR|19|0000002|KS847271C|36127SB=^TSH, 3RD GENERATION W/REFLEX TO FT4^^36127SB=^TSH, 3RD GENERATION W/REFLEX TO FT4|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|55080410^TSH, 3RD GENERATION W/REFLEX TO FT4^^55080410^TSH, 3RD GENERATION W/REFLEX TO FT4^||5.07|mIU/L||H|||F|||20090511111300|KS^^L|||
NTE|1||REFERENCE RANGE:|
NTE|2|| |
NTE|3|| > OR = 20 YEARS: 0.40-4.50|
NTE|4|| |
NTE|5||      PREGNANCY RANGES|
NTE|6|| FIRST TRIMESTER    0.20-4.70|
NTE|7|| SECOND TRIMESTER   0.30-4.10|
NTE|8|| THIRD TRIMESTER    0.40-2.70|
NTE|9|| |
OBR|20|0000002|KS847271C|496SB=^HEMOGLOBIN A1c^^496SB=^HEMOGLOBIN A1c|||20090507064000|||||||20090508205100||^PHYS WELLNESS NETWORK^^|||||KS^Quest Diagnostics-Lenexa^10101 Renner Blvd^Lenexa^KS^66219-9752^Patrick James M.D.|20090511111300|||F|||||||||||||||||||
OBX|1|NM|50026400^HEMOGLOBIN A1c^^50026400^HEMOGLOBIN A1c^||5.5|% of total Hgb|See Note:|N|||F|||20090511111300|KS^^L|||
NTE|1||Reference Range:|
NTE|2|||
NTE|3||NON-DIABETIC: <6.0%|
NTE|4|| |
